Latest news
25 items- 13D/GSEC Form SC 13G/A filed by Vaccitech plc (Amendment)SC 13G/A - Barinthus Biotherapeutics plc. (0001828185) (Subject)
- SECVaccitech plc filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
- INSIDERSEC Form 4 filed by Pelletier Nadege4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- INSIDERSEC Form 4 filed by Griffiths Graham4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- INSIDERSEC Form 4 filed by Enright William4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- INSIDERSEC Form 4 filed by Brown Gemma4 - Barinthus Biotherapeutics plc. (0001828185) (Issuer)
- SECVaccitech plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
- SECVaccitech plc filed SEC Form 8-K: Regulation FD Disclosure, Other Events, Financial Statements and Exhibits8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
- SECSEC Form 10-Q filed by Vaccitech plc10-Q - Barinthus Biotherapeutics plc. (0001828185) (Filer)
- SECVaccitech plc filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
- SECVaccitech plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Barinthus Biotherapeutics plc. (0001828185) (Filer)
- NEWSVaccitech Renames As Barinthus Biotherapeutics To Highlight Strategic Evolution Into A T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, And Cancer; To Trade Under New Name And Ticker 'BRNS' Effective Nov. 7New Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data
- PRVaccitech Renames as Barinthus Biotherapeutics to Highlight Strategic Evolution into a T Cell Immunotherapy Company Targeting Chronic Infectious Diseases, Autoimmunity, and CancerNew Corporate Brand to be Unveiled at AASLD Liver Meeting® 2023 with Interim Data OXFORD, United Kingdom, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Barinthus Biotherapeutics plc (NASDAQ:BRNS), formerly Vaccitech plc (NASDAQ:VACC), a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity and cancer will present data from its Phase 2 Hepatitis B trials of VTP-300 at The American Association for the Study of Liver Diseases (AASLD) – The Liver Meeting® 2023, November 10-14 in Boston, MA. The company also announced today that it has changed its name to Barinthus Biotherapeu
- NEWS12 Health Care Stocks Moving In Tuesday's After-Market SessionGainers Plus Therapeutics (NASDAQ:PSTV) shares rose 20.3% to $1.48 during Tuesday's after-market session. Today's trading volume for this security ended up closing at 1.0 million shares, which is 236.3 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $4.2 million. The company's, Q3 earnings came out today. NewAmsterdam Pharma (NASDAQ:NAMS) shares increased by 11.11% to $10.0. The company's market cap stands at $823.2 million. China SXT Pharmaceuticals (NASDAQ:SXTC) shares increased by 10.23% to $2.37. The company's market cap stands at $1.3 million. DarioHealth (NASDAQ:DRIO) stock moved upwards by 7.81% to $1.38. The market value of
- SECSEC Form DEF 14A filed by Vaccitech plcDEF 14A - Vaccitech plc (0001828185) (Filer)
- NEWS12 Health Care Stocks Moving In Tuesday's Intraday SessionGainers Soleno Therapeutics (NASDAQ:SLNO) shares increased by 426.2% to $23.31 during Tuesday's regular session. Soleno Therapeutics's stock is trading at a volume of 32.5 million shares as of 13:30 EST. This is 51215.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $232.9 million. Femasys (NASDAQ:FEMY) shares rose 272.43% to $1.24. As of 13:30 EST, Femasys's stock is trading at a volume of 147.8 million, which is 3882.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $18.6 million. DMK Pharmaceuticals (NASDAQ:DMK) stock rose 160.42% to $1.18. Trading volume for this secu
- NEWS12 Health Care Stocks Moving In Tuesday's Pre-Market SessionGainers Soleno Therapeutics (NASDAQ:SLNO) shares increased by 386.4% to $21.55 during Tuesday's pre-market session. The company's market cap stands at $215.3 million. Femasys (NASDAQ:FEMY) shares increased by 243.78% to $1.14. The market value of their outstanding shares is at $17.1 million. Intercept Pharma (NASDAQ:ICPT) shares increased by 78.44% to $18.63. The market value of their outstanding shares is at $778.4 million. Immunovant (NASDAQ:IMVT) stock increased by 60.05% to $32.46. The market value of their outstanding shares is at $4.2 billion. Tharimmune (NASDAQ:THAR) stock increased by 54.24% to $0.34. The market value of their outstanding shares is at $5.9 million. Sharps Techn
- SECSEC Form PRE 14A filed by Vaccitech plcPRE 14A - Vaccitech plc (0001828185) (Filer)
- NEWS12 Health Care Stocks Moving In Monday's Intraday SessionGainers TransCode Therapeutics (NASDAQ:RNAZ) shares rose 219.3% to $2.12 during Monday's regular session. TransCode Therapeutics's stock is trading at a volume of 72.3 million shares as of 13:30 EST. This is 12088.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $4.2 million. Vaccitech (NASDAQ:VACC) shares increased by 82.73% to $3.07. Trading volume for Vaccitech's stock is 18.2 million as of 13:30 EST. This is 135511.4% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $118.2 million. Biophytis (NASDAQ:BPTS) shares moved upwards by 71.57% to $1.51. As of 13:30 EST, this se
- NEWSVaccitech Shares Resume Trade
- NEWSVaccitech Shares Halted On Circuit Breaker To The Upside, Stock Now Up 116.1%
- NEWSBenzinga's Top Ratings Upgrades, Downgrades For September 25, 2023Upgrades For Steel Dynamics Inc (NASDAQ:STLD), Citigroup upgraded the previous rating of Neutral to Buy. For the second quarter, Steel Dynamics had an EPS of $4.81, compared to year-ago quarter EPS of $6.73. The current stock performance of Steel Dynamics shows a 52-week-high of $136.46 and a 52-week-low of $69.12. Moreover, at the end of the last trading period, the closing price was at $101.10. Citigroup upgraded the previous rating for Cleveland-Cliffs Inc (NYSE:CLF) from Neutral to Buy. For the second quarter, Cleveland-Cliffs had an EPS of $0.69, compared to year-ago quarter EPS of $1.31. The stock has a 52-week-high of $22.83 and a 52-week-low of $11.82. At the end of the last tradi
- NEWSVaccitech shares are trading higher after Alliance Global Partners initiated a Buy rating on the stock and announced a $12 price target.
- NEWSAlliance Global Partners Initiates Coverage On Vaccitech with Buy Rating, Announces Price Target of $12Alliance Global Partners analyst James Molloy initiates coverage on Vaccitech (NASDAQ:VACC) with a Buy rating and announces Price Target of $12.
- NEWSMorgan Stanley Downgrades Vaccitech to Equal-Weight, Lowers Price Target to $3.25Morgan Stanley analyst Matthew Harrison downgrades Vaccitech (NASDAQ:VACC) from Overweight to Equal-Weight and lowers the price target from $14 to $3.25.